肝细胞癌局部消融:2024年韩国肝癌协会基于专家共识的实践推荐
韩国肝癌协会研究委员会联合韩国影像引导肿瘤消融学会制定2024年肝细胞癌局部消融专家共识实践推荐,涵盖患者选择、术前准备、操作方法和治疗后评估及随访,旨在规范局部消融的临床实践。
要点
- 局部消融已成为早期肝细胞癌的一线治疗选择。
- 射频消融、微波消融和冷冻消融等不同能量来源通过不同机制诱导肿瘤坏死。
- 该共识为局部消融的患者选择、术前准备、操作、治疗后评估和随访提供实践指导。
核心结论
- 韩国肝癌协会研究委员会与韩国影像引导肿瘤消融学会联合制定基于专家共识的局部消融实践推荐,为肝细胞癌局部消融及治疗前后管理提供信息和指导。
研究设计与样本
- 由韩国肝癌协会研究委员会与韩国影像引导肿瘤消融学会的放射科和肝病科专家组成的专家组制定专家共识实践推荐。
临床应用与阅片要点
- 该推荐为局部消融的患者选择、术前准备、操作方法和治疗后快速评估及随访提供实践指导。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Local ablation for hepatocellular carcinoma (HCC), a non-surgical option that directly targets and destroys tumor cells, has advanced significantly since the 1990s. Therapies with different energy sources, such as radiofrequency ablation, microwave ablation, and cryoablation, employ different mechanisms to induce tumor necrosis. The precision, safety, and effectiveness of these therapies have increased with advances in guiding technologies and device improvements. Consequently, local ablation has become the firstline treatment for early-stage HCC. The lack of organized evidence and expert opinions regarding patient selection, pre-procedure preparation, procedural methods, swift post-treatment evaluation, and follow-up has resulted in clinicians following varied practices. Therefore, an expert consensus-based practical recommendation for local ablation was developed by a group of experts in radiology and hepatology from the Research Committee of the Korean Liver Cancer Association in collaboration with the Korean Society of Image-guided Tumor Ablation to provide useful information and guidance for performing local ablation and for the pre- and posttreatment management of patients.
引用
- Han S, Sung PS, Park SY, et al. Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association. J Liver Cancer. 2024. PMID: 39210668. doi:10.17998/jlc.2024.08.04
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。